Pacira Pharmaceuticals, Inc. v. Research Development Foundation

Filing 88

ORDER Granting 87 Stipulation for Extension of Time. Discovery due by 1/30/2023. Signed by Magistrate Judge Daniel J. Albregts on 1/17/2023. (Copies have been distributed pursuant to the NEF - JQC)

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 1 of 6

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

Debra L. Spinelli, Esq., Bar No. 9695
PISANELLI BICE PLLC
400 South 7th Street, Suite 300
Las Vegas, NV 89101
Telephone: [phone]
[e-mail]

Karen A. Peterson, Esq., Bar No. 366
ALLISON MacKENZIE, LTD.
402 North Division Street
Carson City, NV 89703
Telephone: [phone]
[e-mail]

Gregg LoCascio (pro hac vice)
Ronald K. Anguas, Jr. (pro hac vice)
Justin Bova (pro hac vice)
KIRKLAND & ELLIS LLP
1301 Pennsylvania Avenue, N.W.
Washington, D.C. 20004
Telephone: [phone]
[e-mail]
[e-mail]

Daniel S. Leventhal, Esq. (pro hac vice)
Jaime Stark, Esq. (pro hac vice)
NORTON ROSE FULBRIGHT US LLP
1301 McKenney, Suite 5100
Houston, TX 77010
Telephone: [phone]
[e-mail]
[e-mail]

Ryan Kane (pro hac vice)
KIRKLAND & ELLIS LLP
601 Lexington Avenue
New York, NV 10022
Telephone: [phone]
[e-mail]
Andrew Walter (pro hac vice)
KIRKLAND & ELLIS LLP
300 North LaSalle
Chicago, IL 60654
Telephone: [phone]
[e-mail]

Talbot R. Hansum, Esq. (pro hac vice)
Zachary Wegmann, Esq. (pro hac vice)
NORTON ROSE FULBRIGHT US LLP
98 San Jacinto Boulevard, Suite 1100
Austin, TX 78701
Telephone: [phone]
[e-mail]
[e-mail]

17
18
19

James S. Renard, Esq. (pro hac vice)
Brandy S. Nolan, Esq. (pro hac vice)
NORTON ROSE FULBRIGHT US LLP
2200 Ross Avenue, Suite 3600
Dallas, TX 75201
Telephone: [phone]
[e-mail]
[e-mail]

Counsel for Plaintiff, Pacira
Pharmaceuticals, Inc.

Attorneys for Defendant,
Research Development Foundation

20

UNITED STATES DISTRICT COURT

21

DISTRICT OF NEVADA

22
23
24
25
26
27
28

PACIRA PHARMACEUTICALS, INC.,
Plaintiff,
vs.
RESEARCH DEVELOPMENT
FOUNDATION,
Defendant.

Case No. 2:21-cv-02241-CDS-DJA
STIPULATION AND
[PROPOSED] ORDER FOR
EXTENSION OF TIME RE:
ANTHONY MOLLOY AND DR.
MICHNIAK-KOHN
DEPOSITIONS
(FOURTH REQUEST)

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 2 of 6

1

Plaintiff Pacira Pharmaceuticals, Inc. (“Pacira”) and Defendant Research Development

2

Foundation (“RDF”) (collectively, the “Parties”), by and through their respective counsel, and

3

subject to this Court’s approval, agree to modify the Court’s March 30, 2022 Scheduling Order

4

(ECF No. 39), September 12, 2022 Order for Extension of Time (ECF No. 75), October 25, 2022

5

Order for Extension of Time (ECF No. 81), and December 30, 2022 Order for Extension of Time

6

(ECF No. 86) to extend the discovery deadlines. This is the fourth request to modify the

7

Scheduling Order.

8

The Parties seek to extend the discovery cutoff by seventeen (17) days for the purpose of

9

taking the deposition of one of Pacira’s witnesses, Anthony Molloy, and one of RDF’s expert

10

witnesses, Dr. Bozena Michniak-Kohn, as shown in the table below.

11

Description

12

Discovery

13

discovery except with respect

14

to Deposition of Anthony

15

Molloy; Expert Witness

16

Depositions of Messrs.

17

Edwards and Stevens, and Dr.

18

Michniak-Kohn; and

19

Service of Final Privilege

20

Logs 1

21

Discovery cutoff with respect

22

to Depositions of Anthony

23

Molloy and Dr. Michniak-

24

Kohn

cutoff

for

all

Current Deadline

Proposed Deadline

January 13, 2023

Unchanged

January 13, 2023

January 30, 2023

25

This Stipulation is submitted within 21 days of the discovery cutoff. In compliance with

26

LR IA 6-1 and LR 26-3, the Parties submit that good cause exists to extend this deadline. Mr.

27

1

28

The Court has already granted an extension of the discovery cutoff to January 26, 2023 with
respect to expert witness depositions of Messrs. Edwards and Stevens and service of final privilege
logs. Dkt. 86 at 4.
-1-

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 3 of 6

1

Molloy’s deposition was originally scheduled for January 5, 2023. On January 4, 2023, the day

2

before his deposition, Mr. Molloy tested positive for COVID-19. Dr. Michniak-Kohn’s deposition

3

was originally scheduled for January 13, 2023, but Dr. Michiniak-Kohn was still recovering from

4

COVID-19 at the time. The Parties have agreed, subject to the Court’s approval, to postpone Mr.

5

Molloy’s deposition until January 20, 2023 and Dr. Michniak-Kohn’s deposition until January 30,

6

2023. The Parties do not at this time propose extending any other deadlines. In view of Mr.

7

Molloy and Dr. Michniak-Kohn’s illnesses, good cause exists to extend the discovery cutoff by

8

seventeen days for the purpose of taking their depositions.

9
10

This Stipulation is made in good faith, with good cause, and not for purposes of unduly
delaying discovery or trial.

11
12

Respectfully submitted this 12th day of January, 2023.

13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-2-

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 4 of 6

ALLISON MacKENZIE, LTD.

1
2

By:

3
4

/s/ Karen A. Peterson
KAREN A. PETERSON, ESQ.
402 North Division Street
Carson City, NV 89703
DANIEL SCOTT LEVENTHAL, ESQ.
JAIME STARK, ESQ.
NORTON ROSE FULBRIGHT US LLP
1301 McKinney, Suite 5100
Houston, TX 77010-3095

5
6
7

JAMES S. RENARD, ESQ.
BRANDY S. NOLAN, ESQ.
NORTON ROSE FULBRIGHT US LLP
2200 Ross Avenue, Suite 3600
Dallas, TX 75201-7932

8
9
10

TALBOT R. HANSUM, ESQ.
ZACHARY WEGMANN, ESQ.
NORTON ROSE FULBRIGHT US LLP
98 San Jacinto Boulevard, Suite 1100
Austin, TX 78701-4255

11
12

Attorneys for Defendant,
RESEARCH DEVELOPMENT FOUNDATION

13
14

PISANELLI BICE PLLC

15
16
17
18
19
20
21
22
23
24
25
26
27

By:

/s/ Debra L. Spinelli
DEBRA L. SPINELLI, ESQ.
400 South 7th Street, Suite 300
Las Vegas, NV 89101
GREGG LOCASCIO, ESQ.
RONALD K. ANGUAS, JR., ESQ.
JUSTIN BOVA, ESQ.
KIRKLAND & ELLIS LLP
1301 Pennsylvania Avenue, N.W.
Washington, D.C. 20004
RYAN KANE, ESQ.
KIRKLAND & ELLIS LLP
601 Lexington Avenue
New York, NY 10022
ANDREW WALTER, ESQ.
KIRKLAND & ELLIS LLP
300 North LaSalle
Chicago, IL 60654
Attorneys for Plaintiff,
PACIRA PHARMACEUTICALS, INC.

28
-3-

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 5 of 6

ORDER

1
2

The foregoing Stipulation is GRANTED. IT IS HEREBY ORDERED based on the

3

Parties’ foregoing Stipulation, the following modifications to the March 30, 2022 Scheduling

4

Order, September 12, 2022 Order for Extension of Time, October 25, 2022 Order for Extension

5

of Time, and December 30, 2022 Order for Extension of Time (ECF No. 86) are hereby approved

6

and the following discovery and pretrial deadlines extended for good cause shown:

7
8

Description

Deadline

9

Discovery cutoff for all discovery except with

January 13, 2023

10

respect to Deposition of Anthony Molloy;

11

Expert Witness Depositions of Messrs.

12

Edwards and Stevens, and Dr. MichniakKohn; and Service of Final Privilege

13

Logs 2

14

January 30, 2023

Discovery cutoff with respect

15

to Depositions of Anthony Molloy and Dr.

16

Michniak-Kohn

17
18

IT IS SO ORDERED.

19
20

UNITED STATES MAGISTRATE JUDGE

21

January 17, 2023
DATED: ________________________________

22
23

CASE NO. 2:21-cv-02241-CDS-DJA

24
25
26
27
28

2

The Court has already granted an extension of the discovery cutoff to January 26, 2023 with
respect to expert witness depositions of Messrs. Edwards and Stevens and service of final privilege
logs. Dkt. 86 at 4.
-4-

Case 2:21-cv-02241-CDS-DJA Document 88 Filed 01/17/23 Page 6 of 6

1

CERTIFICATE OF SERVICE

2

I hereby certify that I am an employee of Pisanelli Bice PLLC, and that on this day, I

3

electronically filed the foregoing document with the Clerk of the Court by using the CM/ECF

4

system, and that service will be accomplished on all counsel and persons requesting notice by

5

the Court CM/ECF system, which will send notification of such filing to their email addresses.

6

DATED this 12th day of January, 2023.

7
8

/s/ Cinda Towne
An employee of Pisanelli Bice PLLC

9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
-5-